Abstract:Background: Mutations in recombination-activating gene (RAG) 1 and RAG2 are associated with a broad range of clinical and immunologic phenotypes in human subjects. Objective: Using a flow cytometry-based assay, we aimed to measure the recombinase activity of naturally occurring RAG2 mutant proteins and to correlate our results with the severity of the clinical and immunologic phenotype. Methods: Abelson virus-transformed Rag2-/- pro-B cells engineered to contain an inverted green fluorescent protein (GFP) cassette flanked by recombination signal sequences were transduced with retroviruses encoding either wild-type or 41 naturally occurring RAG2 variants. Bicistronic vectors were used to introduce compound heterozygous RAG2 variants. The percentage of GFP-expressing cells was evaluated by using flow cytometry, and high-throughput sequencing was used to analyze rearrangements at the endogenous immunoglobulin heavy chain (Igh) locus. Results: The RAG2 variants showed a wide range of recombination activity. Mutations associated with severe combined immunodeficiency and Omenn syndrome had significantly lower activity than those detected in patients with less severe clinical presentations. Four variants (P253R, F386L, N474S, and M502V) previously thought to be pathogenic were found to have wild-type levels of activity. Use of bicistronic vectors permitted us to assess more carefully the effect of compound heterozygous mutations, with good correlation between GFP expression and the number and diversity of Igh rearrangements. Conclusions: Our data support genotype-phenotype correlation in the setting of RAG2 deficiency. The assay described can be used to define the possible disease-causing role of novel RAG2 variants and might help predict the severity of the clinical phenotype.

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement

RAG-1-deficient mice have no mature B and T lymphocytes

The R229Q mutation of Rag2 does not characterize severe immunodeficiency in mice

RAG gene and B cell lymphoma

Biological Characteristics of Severe Combined Immunodeficient Mice Produced by CRISPR/Cas9-Mediated Rag2 and IL2rg Mutation

Noncore RAG1 regions promote Vβ rearrangements and αβ T cell development by overcoming inherent inefficiency of Vβ recombination signal sequences

Disruption of the RAG2 zinc finger motif impairs protein stability and causes immunodeficiency

RAG2 Abolishes RAG1 Aggregation to Facilitate V(D)J Recombination.

Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency

RAG suppresses group 2 innate lymphoid cells

Recombination activity of human recombination-activating gene 2 (RAG2) mutations and correlation with clinical phenotype

iPSC-Based Modeling of RAG2 Severe Combined Immunodeficiency Reveals Multiple T Cell Developmental Arrests

The RAG1 N-terminal region regulates the efficiency and pathways of synapsis for V(D)J recombination

RAG deficiencies: Recent advances in disease pathogenesis and novel therapeutic approaches

RAG1 splicing mutation causes enhanced B cell differentiation and autoantibody production

The RAG cell line defines a new complementation group of MHC class II deficiency

Hypomorphic mutation in the RAG2 gene affects dendritic cell distribution and migration

RAG2 mutants alter DSB repair pathway choice in vivo and illuminate the nature of ‘alternative NHEJ’

Generation of RAG2 Knockout Immune-Deficient Miniature Pigs

B Cell Development in Mice That Lack One or Both Immunoglobulin Kappa Light Chain Genes.

RAG2 and XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair